Difference between revisions of "Microbiome function"

From Aging Chart
Jump to: navigation, search
(Autoloading by CXLParser)
(Autoloading by CXLParser)
 
Line 132: Line 132:
 
(.//.)<html><!--Pop-up for: Skin barrier function !Pop-up-->
 
(.//.)<html><!--Pop-up for: Skin barrier function !Pop-up-->
 
<div class="1J1RVBFTG-277FVJZ-DYQ" style="display:none;">
 
<div class="1J1RVBFTG-277FVJZ-DYQ" style="display:none;">
 +
  
  
Line 143: Line 144:
 
</div>(...)<!--Pop-up for: Age-related changes in  Immune system functionality !Pop-up-->
 
</div>(...)<!--Pop-up for: Age-related changes in  Immune system functionality !Pop-up-->
 
<div class="1J1RSKZ96-FJ0DVV-C7T" style="display:none;">
 
<div class="1J1RSKZ96-FJ0DVV-C7T" style="display:none;">
 +
  
  
Line 154: Line 156:
 
</div>(...)<!--Pop-up for: Gastrointestinal tract function !Pop-up-->
 
</div>(...)<!--Pop-up for: Gastrointestinal tract function !Pop-up-->
 
<div class="1J1RV8VXB-1TT0VDT-DWZ" style="display:none;">
 
<div class="1J1RV8VXB-1TT0VDT-DWZ" style="display:none;">
 +
  
  
Line 165: Line 168:
 
</div>(...)<!--Pop-up for: Failure of nutrients  Absorbtion !Pop-up-->
 
</div>(...)<!--Pop-up for: Failure of nutrients  Absorbtion !Pop-up-->
 
<div class="1J1RV48Q2-35Q9G4-DSH" style="display:none;">
 
<div class="1J1RV48Q2-35Q9G4-DSH" style="display:none;">
 +
  
  
Line 176: Line 180:
 
</div>(...)<!--Pop-up for: Unbalanced diet !Pop-up-->
 
</div>(...)<!--Pop-up for: Unbalanced diet !Pop-up-->
 
<div class="1J1RSDV06-TM31VS-C0P" style="display:none;">
 
<div class="1J1RSDV06-TM31VS-C0P" style="display:none;">
 +
  
  
Line 187: Line 192:
 
</div>(...)<!--Pop-up for: Age-related changes in  Lifestyle and habits !Pop-up-->
 
</div>(...)<!--Pop-up for: Age-related changes in  Lifestyle and habits !Pop-up-->
 
<div class="1J1RSM6SR-J61R73-C9D" style="display:none;">
 
<div class="1J1RSM6SR-J61R73-C9D" style="display:none;">
 +
  
  
Line 198: Line 204:
 
</div>(...)<!--Pop-up for: Stability in oral, gastrointestinal tract,  Skin and urogenital tract microbiome !Pop-up-->
 
</div>(...)<!--Pop-up for: Stability in oral, gastrointestinal tract,  Skin and urogenital tract microbiome !Pop-up-->
 
<div class="1J1RSQP8X-1MHP3V2-CGR" style="display:none;">
 
<div class="1J1RSQP8X-1MHP3V2-CGR" style="display:none;">
 +
  
  
Line 209: Line 216:
 
</div>(...)<!--Pop-up for: Sensitivity to infection !Pop-up-->
 
</div>(...)<!--Pop-up for: Sensitivity to infection !Pop-up-->
 
<div class="1J1RSK27R-1CBJS3D-C6P" style="display:none;">
 
<div class="1J1RSK27R-1CBJS3D-C6P" style="display:none;">
 +
  
  
Line 220: Line 228:
 
</div>(...)<!--Pop-up for: Admission medications !Pop-up-->
 
</div>(...)<!--Pop-up for: Admission medications !Pop-up-->
 
<div class="1J1RTLBZF-2DSV1MK-DHP" style="display:none;">
 
<div class="1J1RTLBZF-2DSV1MK-DHP" style="display:none;">
 +
  
  
Line 231: Line 240:
 
</div>(...)<!--Pop-up for: Generalized chronic inflammation !Pop-up-->
 
</div>(...)<!--Pop-up for: Generalized chronic inflammation !Pop-up-->
 
<div class="1J1RSPVXM-1SWCRSY-CFZ" style="display:none;">
 
<div class="1J1RSPVXM-1SWCRSY-CFZ" style="display:none;">
 +
  
  
Line 242: Line 252:
 
</div>(...)<!--Pop-up for: Chronic diseases !Pop-up-->
 
</div>(...)<!--Pop-up for: Chronic diseases !Pop-up-->
 
<div class="1J1RTMSFY-1SCX6J5-DM6" style="display:none;">
 
<div class="1J1RTMSFY-1SCX6J5-DM6" style="display:none;">
 +
  
  
Line 253: Line 264:
 
</div>(...)<!--Pop-up for: Toxins into blood !Pop-up-->
 
</div>(...)<!--Pop-up for: Toxins into blood !Pop-up-->
 
<div class="1J1RT1Q3H-3R7GXR-D07" style="display:none;">
 
<div class="1J1RT1Q3H-3R7GXR-D07" style="display:none;">
 +
  
  
Line 264: Line 276:
 
</div>(...)<!--Pop-up for: Tendency to  Obesity !Pop-up-->
 
</div>(...)<!--Pop-up for: Tendency to  Obesity !Pop-up-->
 
<div class="1J1RT4FZ1-JG87MG-D3H" style="display:none;">
 
<div class="1J1RT4FZ1-JG87MG-D3H" style="display:none;">
 +
  
  
Line 275: Line 288:
 
</div>(...)<!--Pop-up for: Biodiversity and number of bacterial cells,  Changes in proportions of different cells  (increasing role of anaerobic patobionts) !Pop-up-->
 
</div>(...)<!--Pop-up for: Biodiversity and number of bacterial cells,  Changes in proportions of different cells  (increasing role of anaerobic patobionts) !Pop-up-->
 
<div class="1J1RS6DP8-G725JQ-BSQ" style="display:none;">
 
<div class="1J1RS6DP8-G725JQ-BSQ" style="display:none;">
 +
  
  

Latest revision as of 10:26, 2 August 2015

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Microbiome function

The human body plays host to a plethora of different microscopic organisms ranging in size and complexity from viruses and bacteria to multicellular, eukaryotic parasitic worms. The bacterial component of the microbiome accounts for roughly 1–3% of body mass with 10 bacteria for every human cell (NIH Human Microbiome Project) and bacterial load is likely to increase with age. Bacteria are found in greatest numbers and variety in the mouth, the gut, and on the skin. Emerging studies indicate that the HM may contribute to the regulation of multiple neuro-chemical and neuro-metabolic pathways through a complex series of highly interactive and symbiotic host-microbiome signaling systems that mechanistically interconnect the gastrointestinal (GI) tract, skin, liver, and other organs with the central nervous system. For example, the human GI tract, containing 95% of the HM, harbors a genetically diverse microbial population that plays major roles in nutrition, digestion, neurotrophism, inflammation, growth, immunity and protection against foreign pathogens.

Bacteria in the mouth, the gut, and on the skin form biofilms. This is a complex ecosystem of different species of bacteria forming a symbiotic whole, enabling the attachment and proliferation of individuals. Biofilm-forming bacteria release a highly hydrated matrix of extracellular polymeric substance, composed of proteins, polyuronic acids, nucleic acids, and lipids. Together bacteria and this matrix form the bulk components of biofilm. Of the estimated 700 oral bacteria identified by DNA, only around 50% have been cultured. The microbiome of the human GI tract is the largest reservoir of microbes in the body, containing about 1014 microorganisms; over 99% of microbiota in the gut are anaerobic bacteria, with fungi, protozoa, archaebacteria and other microorganisms making up the remainder.

As we get older, bacterial load steadily increases as our humoral and cell-mediated immune responses wane in favor of the more primitive, but less efficient, innate immune system. There is growing evidence that the microbiome composition, species identity and combinations, the density and distribution of these bacteria may influence how well we age. Gradually, as the innate immunity predominates over time, certain bacteria may proliferate and trigger more damaging responses. Against a background of rising bacterial load it becomes even more important to maintain the integrity of the blood-brain barrier. Weakening of the blood-brain barrier either, by any predisposing polymorphisms or as a result of conditions that elicit a sustained TNF-α response, may serve to increase the propensity for bacteria or endotoxins to gain access to the brain, trigger neuropathology and alter brain function.